Research Article
Differential Expression and Prognostic Value of Cytoplasmic and Nuclear Cyclin D1 in Prostate Cancer
Table 1
The clinical and pathological characteristics of patients.
| Variables | | Percentage(%) |
| Age (year) | | | <60 | 28 | 14.89% | 60-70 | 83 | 44.15% | >70 | 77 | 40.96% | pT stage | | | pT2 | 113 | 60.11% | pT3+pT4 | 75 | 39.89% | Gleason score | | | ≤6 | 20 | 10.64% | 7 | 89 | 47.34% | ≥8 | 79 | 42.02% | Preoperative PSA level (ng ml-1) | | | <4 | 3 | 1.60% | 4–10 | 36 | 19.15% | 10–20 | 70 | 37.23% | >20 | 79 | 42.02% | pN stage | | | p N0 | 156 | 82.98% | p N1 | 32 | 17.02% | Surgical margin | | | Positive | 82 | 43.62% | Negative | 106 | 56.38% | Prostate capsule invasion | | | Positive | 68 | 36.17% | Negative | 120 | 63.83% | Seminal vesicle invasion | | | Positive | 42 | 22.34% | Negative | 146 | 77.66% | Nerve invasion | | | Positive | 81 | 43.09% | Negative | 107 | 56.91% |
|
|